Speedometer Blog

Friday, November 26, 2021
Andrea Taylor New Analysis Finds that G7+EU Excess Doses Can Cover 40% Supply Gap in 2021 We are excited to announce the release of new analysis and recommendations through our initiative, the COVID Global Accountability Platform (COVID GAP), a collaboration between Duke University and the Covid Collaborative. There are a plethora of dashboards and datasets on COVID-19 response, including vaccine supply and vaccination coverage, providing detail on what is happening both globally and at the country level. However, the existence of these dashboards is not resulting in actions that meet the pressing needs. The COVID GAP pulls together key data across multiple sources to highlight the need and provide evidence-based recommendations to catalyze effective actions and share promising strategies. Our latest report focuses on the 40% and 70% vaccination coverage targets, which have been widely endorsed by global leaders but without any action plan to ensure it happens. Drawing on data from our Launch and Scale Speedometer COVID research, as well as the Multilateral Leaders Task Force on COVID-19, and the WHO, we find that 82 countries (including most low-income and African countries) are not on track to meet 40% vaccination coverage by the end of 2021. At the global level, this is not a supply issue but a distribution issue. The scale up of COVID-19 vaccine production over the past year has been staggeringly successful; the world is now making about 1.5 billion doses a month. We have enough doses to vaccinate far more than 40% of the population in every country. However, much of this supply is concentrated in a small number of wealthy countries, who have more than they can use. Based on supply and vaccination rate data, we expect G7 and EU countries to collectively have more than 830 million excess doses at the end of 2021. Meanwhile, many countries still face significant supply gaps. For the countries that have not yet reached 40% coverage, our analysis indicates that a further 1.05 billion doses are still needed to reach the target. After expected COVAX deliveries in November and December, these countries will still face a gap of 650 million doses. Driven by this analysis, the COVID GAP team urgently recommends that vaccine makers and donor countries: • Improve transparency on vaccine production, supply, and allocation to drive accountability and effective vaccination planning – countries need advance notice of delivery schedules • Allocate increasing supply of vaccines more equitably, through “queue swapping” and fulfilling donation pledges • Strengthen country-level capacity to ensure doses get from airports into arms as quickly and efficiently as possible Future analyses will focus on the quantifying the need and tracking commitments for therapeutics, diagnostics, and oxygen, as well as future preparedness. The COVID GAP team is working closely with leaders in low- and middle-income countries as well as multilateral organizations and major funders to build stronger data on the challenges, bottlenecks, and promising strategies to advance access to COVID-19 vaccines, therapeutics, and other resources around the world. We will continue to update the data and insights on the covid19gap.org website, just as we do for the Launch and Scale Speedometer COVID data and will draw on these analyses to develop practical recommendations. As always, we welcome input on how you are using these analyses and if there are particular areas of focus for our data tracking through Launch and Scale Speedometer or COVID GAP that would be helpful.
Thursday, November 18, 2021
Widespread administration of oral polio vaccines (OPVs) has resulted in reduced incidence of polio and the eradication of wild poliovirus type 2 and type 31,2.
Friday, October 29, 2021
Most high income and upper middle-income countries have fully vaccinated more than half of their population.
Friday, September 24, 2021
As we and a coalition of over 100 leaders and organizations called for, President Biden hosted a Global COVID-19 Summit on Wednesday. With participation of world leaders mostly virtually, the Summit covered familiar ground as well as some new territory.
Saturday, September 18, 2021
Deliveries of vaccine donations are more important than ever, given the persistent gaps in vaccine coverage globally and threat of the highly contagious delta variant.
Saturday, September 11, 2021
Cuba has become the leader of COVID-19 vaccine development in Latin America – producing a total of five vaccine candidates so far, four of which are awaiting submission to WHO’s Emergency Use Listing Procedure (EUL).
Friday, August 27, 2021
The past 18 months have shown us what happens when we rely on fragmented responses to a pandemic – the result is an uncoordinated patchwork of insufficient approaches and the continued spread of an ever-mutating virus. It sounds obvious but still needs to be said: pandemics are global and our response must be as well.
Friday, August 20, 2021
The US has continued to advance plans for boosters since we wrote about the issue earlier this month, with an announcement that a third dose will be offered to all residents (not just the highly vulnerable), eight months after the second dose.
Friday, August 13, 2021
Despite the shortage of Covid-19 vaccines globally, millions of doses are being wasted rather than used. Vaccine wastage is defined as vaccines discarded, lost, damaged or destroyed according to the WHO.
Friday, August 6, 2021
A handful of wealthy countries recently announced plans to roll out booster shots in late 2021 for vulnerable populations already fully vaccinated against Covid-19.
Friday, July 23, 2021
While businesses return to full capacity and mask mandates are lifted in much of the US and several other countries with relatively high vaccination rates, there is growing concern about the impact from the rapidly spreading COVID-19 delta variant.
Friday, July 16, 2021
Of the 3.5 billion COVID-19 vaccine doses that have been administered globally, only about 69 percent of the doses have been administered in low and middle income countries (LMICs) with 84 percent of the world’s population. Wealthy nations’ over-purchasing of the limited vaccine supply left LMIC nations without access to COVID-19 vaccine doses.
Friday, July 9, 2021
Many countries in Africa, Asia, and Latin America have yet to receive the vaccines necessary to slow the spread of Covid-19 despite recent purchase and donation agreements. In recent weeks, large scale donations of Covid-19 vaccines have made headlines as the US and EU promised to send hundreds of millions of doses to low- and middle-income countries (LMICs).
Friday, July 2, 2021
We are excited to release new data this week, tracking vaccine donations by donor country, recipient (cut by continent and income category), and vaccine. Our data include doses that have been pledged, regardless of whether they have already been delivered. The interactive visualizations show which countries are the big donors, which vaccines are being donated, and where they are going.
Friday, June 18, 2021
The G7 began their much-anticipated summit last week with a target to reach 1 billion doses of Covid-19 vaccine in pledged donations for low- and middle-income countries (LMICs). The result could be described as underwhelming (as well as unclear).